Table 4 Antibiotic susceptibility profiles of the Gram-positive MDR ESKAPEE bacterial pathogens
Antimicrobial agent | MRSA, n = 5 (%) | E. faecium and E. faecalis, n = 2 (%) | ||
|---|---|---|---|---|
| Â | NS | S | NS | S |
Cefoxitin | 5 (100) | 0 | nd | nd |
Penicillin | 5 (100) | 0 | nd | nd |
Oxacillin | 5 (100) | 0 | nd | nd |
Erythromycin | 5 (100) | 0 | 2 (100) | 0 |
Gentamycin | 5 (100) | 0 | nd | nd |
Clindamycin | 5 (100) | 0 | nd | nd |
Linezolid | 0 | 5/5 (100) | 0 | 2 (100) |
Levofloxacin | 4 (80) | 1/5 (20.0) | 2 (100) | 0 |
Moxifloxacin | 4 (80) | 1/5 (20.0) | ND | nd |
Tetracycline | 3 (60) | 2/5 (40.0) | 2 (100) | 0 |
Tigecycline | 0 | 5/5 (100) | 0 | 2 (100) |
Nitrofurantoin | 0 | 5/5 (100) | 2 (100) | 0 |
Trimethoprim-sulfamethoxazole | 5 (100) | 0 | nd | nd |
Teicoplanin | 0 | 5/5 (100) | 0 | 2 (100) |
Vancomycin | 0 | 5/5 (100) | 0 | 2 (100) |
Fusidic Acid | 0 | 5/5 (100) | nd | nd |